GO:0032649 regulation of type II interferon production: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032649 (regulation of type II interferon production) describes any process that modulates the frequency, rate, or extent of interferon-gamma (IFN-gamma) production.
• IFN-gamma is a type II interferon critical for macrophage activation, antigen presentation, and host defense, and its production is tightly controlled at transcriptional and post-transcriptional levels.
• Key regulators include transcription factors (T-bet, STAT4), RNA-binding proteins (ZFP36L2), and metabolic sensors such as IRE1alpha-XBP1.
• Dysregulated IFN-gamma production contributes to autoimmune diseases, chronic infections, and cancer immune evasion.
• Experimental models for studying this process include knockout mice, point-mutant knock-in cells, and overexpression systems, often combined with CRISPR screening.
• EDITGENE provides CRISPR-based services to dissect the regulatory network of IFN-gamma production, from gene knockout to library screening and bioinformatics.
Description
Regulation of type II interferon production (GO:0032649) encompasses all biological processes that control the synthesis, secretion, or bioavailability of interferon-gamma (IFN-gamma), also known as type II interferon. IFN-gamma is a pleiotropic cytokine produced primarily by activated T cells and natural killer (NK) cells, and it plays central roles in immune responses against intracellular pathogens and tumors. The precise regulation of IFN-gamma production is essential to mount effective immunity while preventing immunopathology. This GO term captures the diverse molecular mechanisms that modulate IFN-gamma levels, including transcriptional activation, post-transcriptional stability, and secretion. Understanding these regulatory layers is critical for researchers in immunology, cancer biology, and infectious diseases, as IFN-gamma dysregulation is linked to autoimmunity, chronic inflammation, and impaired tumor control. Moreover, IFN-gamma production is influenced by metabolic and stress pathways, such as the IRE1alpha-XBP1 axis, which integrates cellular stress with T cell function. This article provides a comprehensive overview of the ontology, key genes, regulatory mechanisms, and experimental approaches to study GO:0032649, with a focus on CRISPR-based models and services offered by EDITGENE.
regulation of type II interferon production At A Glance
| GO ID | GO:0032649 |
|---|---|
| GO term | regulation of type II interferon production |
| Ontology | biological_process |
| Synonym | regulation of interferon-gamma biosynthetic process; regulation of interferon-gamma production; regulation of interferon-gamma secretion |
| Major function | Modulates the frequency, rate, or extent of interferon-gamma production |
| Interferon type | Type II interferon (IFN-gamma) |
| Cellular source | Activated T cells, NK cells, and other immune cells |
| Regulatory layers | Transcriptional, post-transcriptional, and secretory control |
| Disease relevance | Autoimmunity, cancer, infectious diseases |
What Is GO:0032649?
According to the Gene Ontology, GO:0032649 (regulation of type II interferon production) is defined as any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. This term includes the regulation of interferon-gamma biosynthetic process, production, and secretion. It encompasses both positive and negative regulation, and it applies to the molecular events that control the levels of IFN-gamma in a cell or organism.
Why Is regulation of type II interferon production Important in Cell Biology?
Regulation of type II interferon production is a cornerstone of immune homeostasis because IFN-gamma orchestrates macrophage activation, upregulation of MHC molecules, and Th1 immune responses. Imbalances in IFN-gamma levels can lead to severe immunopathology: excessive production is associated with autoimmune conditions such as systemic lupus erythematosus, while insufficient production impairs pathogen clearance and tumor surveillance. Therefore, deciphering the regulatory mechanisms of GO:0032649 is essential for developing targeted immunotherapies and understanding disease pathogenesis.
• Controls Th1 immune responses and macrophage activation.
• Dysregulation linked to autoimmune diseases like lupus and rheumatoid arthritis.
• Critical for host defense against intracellular bacteria and viruses.
• Influences tumor immune surveillance and immunotherapy outcomes.
• Modulated by metabolic stress pathways such as IRE1alpha-XBP1 in T cells.
• Post-transcriptional regulation by RNA-binding proteins like ZFP36L2 affects IFN-gamma mRNA stability.
• Exosomal microRNAs from maternal tissues can suppress NK cell IFN-gamma production.
• Type I interferons crosstalk with type II interferon regulation during bacterial infection.
• IFN-gamma can induce melanogenesis, linking immune regulation to pigmentation.
• Therapeutic targeting of IFN-gamma production is explored in autoimmunity and cancer.
What Happens During regulation of type II interferon production?
Transcriptional Activation of IFNG
In simple terms: This step turns on the gene that makes IFN-gamma.
Upon T cell receptor stimulation, transcription factors such as T-bet and STAT4 are activated and bind to the IFNG promoter and enhancer regions, initiating transcription. This transcriptional activation is a primary point of regulation for type II interferon production. The IRE1alpha-XBP1 arm of the unfolded protein response also supports T cell function and IFN-gamma production in the tumor microenvironment.
Post-transcriptional Regulation of IFN-gamma mRNA
In simple terms: This step controls how long the IFN-gamma message lasts before being degraded.
After transcription, IFN-gamma mRNA stability is regulated by RNA-binding proteins. ZFP36L2 (TTP-like protein) binds to AU-rich elements in the 3' untranslated region of IFNG mRNA and promotes its degradation, thereby limiting IFN-gamma production in a time-dependent manner. This post-transcriptional control ensures that IFN-gamma production is transient and tightly regulated.
Secretion and Extracellular Regulation
In simple terms: This step releases IFN-gamma from the cell and controls its availability outside.
IFN-gamma is secreted through the classical secretory pathway. Regulation of secretion can occur at the level of vesicle trafficking and exocytosis. Additionally, extracellular factors such as exosomal miR-29a-3p from villus-derived exosomes can suppress NK cell production of IFN-gamma, as shown in pregnancy and recurrent pregnancy loss models. This highlights that regulation of type II interferon production extends beyond the producing cell.
Crosstalk with Other Cytokines and Interferons
In simple terms: Other signals can turn IFN-gamma production up or down.
Type I interferons (IFN-alpha/beta) can modulate type II interferon production during bacterial infection, creating a crosstalk network that shapes myeloid cell responses. Interleukin-4 and IFN-gamma can synergize to induce arginase-1 in macrophages, illustrating how IFN-gamma signaling integrates with other cytokines. These interactions fine-tune the overall immune response.
Metabolic and Stress Integration
In simple terms: Cellular stress and metabolism can affect IFN-gamma production.
The IRE1alpha-XBP1 pathway controls T cell function in ovarian cancer by regulating mitochondrial activity, which in turn influences IFN-gamma production. This demonstrates that metabolic fitness and stress responses are integral to the regulation of type II interferon production. Targeting these pathways may enhance anti-tumor immunity.
Key Genes Involved in GO:0032649 regulation of type II interferon production
The following genes and proteins are key players in the regulation of type II interferon production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IFNG | Encodes interferon-gamma, the type II interferon | Central to all studies of GO:0032649; knockout and reporter models |
| TBX21 (T-bet) | Transcription factor that induces IFNG expression | Master regulator of Th1 responses; knockout reduces IFN-gamma |
| STAT4 | Transcription factor activated by IL-12, promotes IFNG transcription | Knockout mice have impaired IFN-gamma production |
| ZFP36L2 | RNA-binding protein that destabilizes IFNG mRNA | Post-transcriptional control; knockout increases IFN-gamma |
| IRE1alpha (ERN1) | Stress sensor that supports T cell function and IFN-gamma production | Target in cancer immunotherapy |
| XBP1 | Transcription factor downstream of IRE1alpha | Regulates mitochondrial activity and IFN-gamma in T cells |
| IL12A/IL12B | Cytokines that induce IFN-gamma production | Upstream regulators; used in activation protocols |
| IL4 | Cytokine that can synergize with IFN-gamma | Modulates macrophage responses |
| ARG1 | Arginase-1, induced by IL-4 and IFN-gamma | Marker of macrophage polarization |
| NKG2D | Activating receptor on NK cells | Influences NK cell IFN-gamma production |
| KIR | Killer cell immunoglobulin-like receptors | Regulate NK cell activation and IFN-gamma |
| miR-29a-3p | MicroRNA that suppresses NK cell IFN-gamma production | Exosomal transfer in pregnancy |
| IFNGR1 | Receptor for IFN-gamma | Mediates feedback and crosstalk |
| IFNGR2 | Accessory receptor for IFN-gamma | Signaling and regulation |
| STAT1 | Transcription factor downstream of IFN-gamma receptor | Mediates IFN-gamma responses and feedback |
| IRF1 | Transcription factor induced by IFN-gamma | Amplifies IFN-gamma responses |
| SOCS1 | Suppressor of cytokine signaling | Negative feedback on IFN-gamma signaling |
| TYK2 | Kinase associated with IFN-gamma receptor | Required for IFN-gamma signaling |
How Is regulation of type II interferon production Regulated?
Regulation of type II interferon production is controlled at multiple levels. Transcriptionally, T-bet and STAT4 activate IFNG in response to T cell receptor and IL-12 signaling. Post-transcriptionally, ZFP36L2 promotes IFN-gamma mRNA decay, limiting production. The IRE1alpha-XBP1 pathway links metabolic stress to IFN-gamma production in T cells. Additionally, type I interferons can modulate type II interferon production during bacterial infection. Exosomal microRNAs such as miR-29a-3p can suppress NK cell IFN-gamma production. These layers ensure that IFN-gamma is produced appropriately in magnitude and duration.
regulation of type II interferon production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IFNG | Autoimmunity, cancer, infections | Knockout mice, reporter cell lines |
| ZFP36L2 | Inflammation, autoimmunity | Knockout and point-mutant cells |
| ERN1 (IRE1alpha) | Ovarian cancer | Knockout T cells, tumor models |
| XBP1 | Cancer, metabolic stress | Knock-in reporters, knockout |
| miR-29a-3p | Recurrent pregnancy loss | Exosome transfer, NK cell assays |
Autoimmune Diseases
Dysregulated IFN-gamma production is a hallmark of systemic autoimmunity. Elevated IFN-gamma levels contribute to tissue damage in lupus, rheumatoid arthritis, and other autoimmune conditions. Understanding the regulation of type II interferon production is therefore critical for developing therapies that target IFN-gamma pathways.
Cancer
In the tumor microenvironment, IFN-gamma is essential for anti-tumor immunity, but tumors can evade it. The IRE1alpha-XBP1 pathway controls T cell function and IFN-gamma production in ovarian cancer, and targeting this pathway may improve immunotherapy. IFN-gamma also induces melanogenesis, linking immune regulation to melanoma biology.
Infectious Diseases
IFN-gamma is crucial for host defense against intracellular pathogens. Crosstalk between type I and type II interferons regulates myeloid cell responses during bacterial infection, and imbalances can lead to immunopathology. Regulation of type II interferon production is thus central to infectious disease outcomes.
Pregnancy and Reproductive Immunology
In normal pregnancy, villus-derived exosomal miR-29a-3p suppresses decidual NK cell production of IFN-gamma, and its dysregulation is associated with unexplained recurrent pregnancy loss. This highlights the importance of IFN-gamma regulation in reproductive immunology.
From regulation of type II interferon production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IFN-gamma production? | CRISPR knockout in primary T cells or Jurkat |
| Does a point mutation in gene X affect IFN-gamma? | Point-mutation knock-in via HDR |
| Does overexpression of gene X enhance IFN-gamma? | Lentiviral overexpression in NK or T cells |
| Where is gene X expressed during IFN-gamma production? | Tagged knock-in (e.g., GFP) reporter |
| What is the transcriptional response? | RNA-seq after CRISPR perturbation |
| Which genes regulate IFN-gamma in a genome-wide manner? | CRISPR library screening |
How to Study the regulation of type II interferon production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify regulators of IFNG transcription |
| ELISA | Secreted IFN-gamma protein | Quantify production in cell supernatants |
| Flow cytometry | Intracellular IFN-gamma | Analyze single-cell production in T/NK cells |
| RIP-qPCR | Protein-RNA interactions | Study ZFP36L2 binding to IFNG mRNA |
| Seahorse assay | Mitochondrial respiration | Link metabolism to IFN-gamma |
| CRISPR screen | Genome-wide regulators | Discover novel genes controlling IFN-gamma |
| Western blot | Protein expression | Validate knockout or overexpression |
Transcriptional Profiling
RNA-seq and qPCR can measure IFNG mRNA levels and identify transcriptional changes in response to regulators. These methods are used to assess the impact of CRISPR knockouts on IFN-gamma production.
Protein Detection
ELISA and flow cytometry are standard for quantifying secreted and intracellular IFN-gamma protein. These assays are essential for validating regulatory mechanisms.
Post-transcriptional Analysis
RNA immunoprecipitation (RIP) and mRNA stability assays can determine how RNA-binding proteins like ZFP36L2 affect IFNG mRNA half-life.
Metabolic and Stress Assays
Seahorse analysis and mitochondrial function assays can link metabolic pathways such as IRE1alpha-XBP1 to IFN-gamma production.
How CRISPR Can Be Used to Study GO:0032649 regulation of type II interferon production
Knockout
CRISPR knockout of candidate genes (e.g., ZFP36L2, ERN1) in T cells or NK cells can reveal their role in IFN-gamma production. For example, ZFP36L2 knockout increases IFN-gamma mRNA stability and production.
Point Mutation
Point mutations can be introduced to study specific residues or regulatory elements. For instance, mutating phosphorylation sites in transcription factors can affect IFNG transcription.
Knock-in
Knock-in of reporter genes (e.g., GFP) into the IFNG locus allows real-time monitoring of IFN-gamma production. Tagged knock-in of regulatory proteins can track their localization.
Overexpression
Overexpression of regulators such as XBP1 or miR-29a-3p can suppress or enhance IFN-gamma production, providing gain-of-function evidence.
How EDITGENE Supports regulation of type II interferon production Research
Researchers studying regulation of type II interferon production-related genes often need to determine whether a candidate gene is causally involved in IFN-gamma regulation. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery, from single-gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of type II interferon production research.
Frequently Asked Questions About regulation of type II interferon production
What is GO:0032649?
GO:0032649 is the Gene Ontology term for regulation of type II interferon production, defined as any process that modulates the frequency, rate, or extent of interferon-gamma production.
What is type II interferon?
Type II interferon is interferon-gamma (IFN-gamma), a cytokine primarily produced by T cells and NK cells that is critical for immune responses against pathogens and tumors.
What genes are involved in regulation of type II interferon production?
Key genes include IFNG, TBX21 (T-bet), STAT4, ZFP36L2, ERN1 (IRE1alpha), XBP1, and others listed in the key genes table.
How is IFN-gamma production regulated?
It is regulated at transcriptional, post-transcriptional, and secretory levels, involving transcription factors, RNA-binding proteins, and metabolic pathways.
What diseases are associated with dysregulated IFN-gamma production?
Autoimmune diseases like lupus, cancer, and infectious diseases are associated with dysregulated IFN-gamma production.
What experimental models are used to study GO:0032649?
Common models include CRISPR knockout mice or cell lines, point-mutant knock-ins, reporter knock-ins, and overexpression systems.
How can CRISPR help study regulation of type II interferon production?
CRISPR enables precise gene knockout, point mutation, knock-in, and overexpression to dissect the regulatory network of IFN-gamma production.
What is the role of ZFP36L2 in IFN-gamma regulation?
ZFP36L2 is an RNA-binding protein that destabilizes IFNG mRNA, thereby limiting IFN-gamma production in a time-dependent manner.
How does IRE1alpha-XBP1 affect IFN-gamma production?
The IRE1alpha-XBP1 pathway supports T cell mitochondrial activity and function, which is necessary for optimal IFN-gamma production in the tumor microenvironment.
Can exosomal microRNAs regulate IFN-gamma production?
Yes, exosomal miR-29a-3p from villus-derived exosomes suppresses decidual NK cell production of IFN-gamma, as shown in pregnancy studies.
Conclusion
Regulation of type II interferon production (GO:0032649) is a vital biological process that ensures appropriate IFN-gamma levels for effective immunity while preventing immunopathology. The interplay of transcriptional activators, post-transcriptional repressors, and metabolic sensors creates a robust regulatory network. Dysregulation of this process is implicated in autoimmunity, cancer, and infectious diseases, making it a key area of biomedical research. Advances in CRISPR technology, combined with EDITGENE's services, empower researchers to dissect these mechanisms and develop novel therapeutic strategies.
References
- 1. Song M et al.. 2018. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.. Nature 562(7727):423-428 PMID: 30305738
- 2. Mo X et al.. 2022. Interferon-gamma induces melanogenesis via post-translational regulation of tyrosinase.. Pigment Cell Melanoma Res 35(3):342-355 PMID: 35266648
- 3. Fang Z et al.. 2024. Increased levels of villus-derived exosomal miR-29a-3p in normal pregnancy than uRPL patients suppresses decidual NK cell production of interferon-γ and exerts a therapeutic effect in abortion-prone mice.. Cell Commun Signal 22(1):230 PMID: 38627796
- 4. Zandhuis ND et al.. 2024. Regulation of IFN-γ production by ZFP36L2 in T cells is time-dependent.. Eur J Immunol 54(10):e2451018 PMID: 38980256
- 5. Endo TH et al.. 2023. Synergy of interleukin-4 and interferon-γ in arginase-1 production in RAW264.7 macrophages.. Asian Pac J Allergy Immunol 41(4):379-388 PMID: 34542303
- 6. Crisler WJ et al.. 2018. Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.. Curr Opin Immunol 54:35-41 PMID: 29886270
- 7. Pollard KM et al.. 2013. Interferon-γ and systemic autoimmunity.. Discov Med 16(87):123-31 PMID: 23998448
